KETAMINE FAQ

Ketamine Therapy has become a breakthrough treatment in mental health care. It can be administered in a clinical setting given as an intravenous infusion or nasal spray. Ketamine is effective in about 70% of patients with treatment-resistant depression.

Yes. When administered by trained medical professionals in a controlled setting, ketamine therapy is considered safe. It's important to discuss your medical history and any potential risks with your healthcare provider.

Ketamine can be administered intravenously (IV) or as a nasal spray. There are two types of ketamine: racemic ketamine and esketamine. Racemic ketamine combines two molecules: "R" and "S" ketamine. It was originally approved for anesthesia. Now, in smaller doses, it can treat mental health conditions. Ketamine infusions are not covered by insurance.

Esketamine also known as Spravato, is the FDA approved nasal spray that only uses the "S" molecule. Intranasal Esketamine is covered by many major insurance companies. Our medical staff will discuss your options and answer any questions you may have about ketamine treatment.

Many individuals experience a noticeable improvement in their depression symptoms within hours to days after a ketamine treatment, as opposed to traditional antidepressants that can take weeks to show effects. As with any treatment, individual results may vary.

The duration of relief can vary from person to person. Some may find relief for a few weeks, while others may experience longer-lasting effects. Maintenance sessions are often recommended to sustain the benefits.

Common side effects may include dizziness, nausea, and dissociation (feeling detached from reality). These effects are usually short-lived and subside after the treatment.

To begin ketamine therapy, schedule a consultation using this link or give our team a call at (800) 732-9822. We will help assess your condition, discuss treatment options, and create a personalized plan tailored to your needs.